NCT01880125View on ClinicalTrials.gov

Assessment of the Pharmacokinetics of a Sustained Release Formulation of a Tramadol/Acetaminophen Combination

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

May 31, 2012

Study Completion Date

May 31, 2012

Conditions
Pain
Interventions
DRUG

Tramadol HCI/Acetaminophen

Test drug: Tramadol HCI/Acetaminophen 75/650mg, two times daily. Reference drug: Tramadol HCI/Acetaminophen 37.5/325 mg, four times daily.

All Listed Sponsors
collaborator

Chonbuk National University Hospital

OTHER

lead

Yungjin Pharm. Co., Ltd.

INDUSTRY

NCT01880125 - Assessment of the Pharmacokinetics of a Sustained Release Formulation of a Tramadol/Acetaminophen Combination | Biotech Hunter | Biotech Hunter